|
CKS1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.275200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.668000E-01 |
| Normal-vs-Stage2 |
1.129630E-01 |
| Normal-vs-Stage3 |
1.378950E-01 |
| Normal-vs-Stage4 |
1.098630E-01 |
| Stage1-vs-Stage2 |
4.265700E-02 |
| Stage1-vs-Stage3 |
1.535770E-01 |
| Stage1-vs-Stage4 |
1.068190E-01 |
| Stage2-vs-Stage3 |
5.078500E-03 |
| Stage2-vs-Stage4 |
8.537500E-03 |
| Stage3-vs-Stage4 |
6.036800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.830200E-01 |
| Normal-vs-AfricanAmerican |
1.718830E-01 |
| Normal-vs-Asian |
3.078800E-01 |
| Caucasian-vs-AfricanAmerican |
3.220400E-01 |
| Caucasian-vs-Asian |
7.871000E-01 |
| AfricanAmerican-vs-Asian |
4.820000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.573400E-01 |
| Normal-vs-Female |
2.719000E-01 |
| Male-vs-Female |
5.991600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.208000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.377200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.513000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.870600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.676000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.962000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.883200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.146000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.349800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.751200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.716400E-02 |
| Classical-VS-Follicular |
1.86070003849181E-09 |
| Classical-VS-Other |
3.041800E-01 |
| Classical-VS-Normal |
7.705900E-02 |
| Tall-VS-Follicular |
1.07439999996739E-06 |
| Tall-VS-Other |
6.270300E-02 |
| Tall-VS-Normal |
1.684780E-03 |
| Follicular-VS-Other |
3.889200E-01 |
| Follicular-VS-Normal |
9.160000E-04 |
| Other-VS-Normal |
7.250200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.213000E-01 |
| Normal-vs-N1 |
8.309600E-01 |
| N0-vs-N1 |
4.761800E-01 |
|
|
